Sugargic MV 1mg/500mg/0.2mg Tablet SR
Marketer
Neorangic Healthcare Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Sugargic MV 1mg/500mg/0.2mg Tablet SR
Diabetic patients may find relief with the anti-diabetic medication, Glycemia-Control SR 1mg/500mg/0.2mg tablet, a combination therapy for adult type 2 diabetes. This medication assists in blood glucose regulation. Administer Glycemia-Control SR with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood glucose monitoring. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as advised by your doctor. Common side effects include hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a quick-acting glucose source (e.g., sugary sweets or juice). Alcohol increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Glycemia-Control SR is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any prior heart conditions before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose checks, along with blood cell and liver function tests as advised by your physician, are necessary.
Uses of Sugargic MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sugargic MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Sugargic MV 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
Common Side effects of Sugargic MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Sugargic MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sugargic MV 1mg/500mg/0.2mg Tablet SR on an empty stomach.
How Sugargic MV 1mg/500mg/0.2mg Tablet SR works:
Each Sugargic MV SR tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sugargic MV 1mg/500mg/0.2mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Sugargic MV 1mg/500mg/0.2mg Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sugargic MV 1mg/500mg/0.2mg tablet likely poses a risk to breastfeeding infants. Available human evidence indicates potential transfer to breast milk, possibly causing harm to the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Sugargic MV 1mg/500mg/0.2mg Tablet SR carries a high risk for individuals with kidney impairment and is best avoided. Medical advice is essential. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Sugargic MV 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Sugargic MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take your Sugargic MV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Sugargic MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently